Skip to main content
DGX logo

DGX · Quest Diagnostics Inc

$238.50 +2.66 (+1.13%) At close · Aug 6
Market Cap
$26.32B
Shares
110.37M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization
$1,300,000,000
as of 2026-06-30

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-06-30 YTD $102,000,000
2025-12-31 $450,000,000
2024-12-31 $151,000,000
2023-12-31 $275,000,000
2022-12-31 $1,408,000,000
2021-12-31 $2,199,000,000
2020-12-31 $325,000,000
2019-12-31 $353,000,000
2018-12-31 $322,000,000
2017-12-31 $465,000,000
2016-12-31 $590,000,000
2015-12-31 $224,000,000
2014-12-31 $132,000,000
2013-12-31 $1,037,000,000
2012-12-31 $200,000,000
2011-12-31 $935,000,000
2010-12-31 $750,000,000
2009-12-31 $499,991,000
2008-12-31 $253,997,000
2007-12-31 $145,660,000
Key facts CIK 1022079 CUSIP 74834L100 13F (30d) 578 filings 551 filers Visit website Investor relations